Playback speed
10 seconds
This video is featured in the 2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Adjuvant Ribociclib + NSAI in HR+/HER2- eBC - 4-Year Outcomes From the NATALEE Trial
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Peter Fasching
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Peter Fasching
7 views
November 19, 2024
Comments 0
Login to view comments.
Click here to Login